VCV002499992.2 - ClinVar

NM_001015048.3(BAG5):c.321_322del (p.Lys108fs)

Germline

Classification

The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.

(1)

Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.

Likely pathogenic

no assertion criteria provided

Somatic

No data submitted for somatic clinical impact

Somatic

No data submitted for oncogenicity

Variant Details

Identifiers

NM_001015048.3(BAG5):c.321_322del (p.Lys108fs)

Variation ID: 2499992 Accession: VCV002499992.2

Type and length

Microsatellite, 2 bp

Location

Cytogenetic: 14q32.33 14: 103560843-103560844 (GRCh38) [ NCBI UCSC ] 14: 104027180-104027181 (GRCh37) [ NCBI UCSC ]

Timeline in ClinVar

	First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.	Last submission Help The date of the most recent submission for each type of classification for this variant.	Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline	Apr 30, 2023	Apr 30, 2023

HGVS

Nucleotide	Protein	Molecular consequence
NM_001015048.3:c.321_322del MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.	NP_001015048.1:p.Lys108fs	frameshift
NM_001015049.5:c.321_322del	NP_001015049.2:p.Lys108fs	frameshift
NM_004873.4:c.321_322del	NP_004864.1:p.Lys108fs	frameshift
NC_000014.9:g.103560843TC[3]
NC_000014.8:g.104027180TC[3]
NG_041786.1:g.2887TC[3]

... more HGVS ... less HGVS

Protein change

K108fs

Other names

Canonical SPDI

NC_000014.9:103560842:TCTCTCTC:TCTCTC

Functional consequence Help The effect of the variant on RNA or protein function, based on experimental evidence from submitters.

protein loss of function; Variation Ontology [ VariO:0043]

Global minor allele frequency (GMAF) Help The global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.

Allele frequency Help The frequency of the allele represented by this VCV record.

Links

VarSome

Genes

Gene	OMIM	ClinGen Gene Dosage Sensitivity Curation		Variation Viewer Help Links to Variation Viewer, a genome browser to view variation data from NCBI databases.	Related variants
Gene	OMIM	HI score Help The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.	TS score Help The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team.		Within gene Help The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants.	All Help The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene.
BAG5		-	-	GRCh38 GRCh37	37	100

Conditions - Germline

Condition Help The condition for this variant-condition (RCV) record in ClinVar.	Classification Help The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions)	Review status Help The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status.	Last evaluated Help The most recent date that a submitter evaluated this variant for the condition.	Variation/condition record Help The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page.
Cardiomyopathy	Likely pathogenic (1)	no assertion criteria provided	-	RCV003224082.1

Submissions - Germline

Classification Help The submitted germline classification for each SCV record. (Last evaluated)	Review status Help Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria)	Condition Help The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
Likely pathogenic (-)	no assertion criteria provided Method: clinical testing, in vivo	Cardiomyopathy (Autosomal recessive inheritance) Affected status: no, yes, not applicable Allele origin: inherited, not applicable	Center of Excellence for Medical Genomics, Chulalongkorn University Accession: SCV003918808.1 First in ClinVar: Apr 30, 2023 Last updated: Apr 30, 2023	Publications: PubMed (1) PubMed: 35044787 Observation 1: Clinical Features: Primary dilated cardiomyopathy (present) Age: 10-19 years Sex: male Geographic origin: United Arab Emirates (UAE) Observation 2: Clinical Features: Primary dilated cardiomyopathy (present) Age: 20-29 years Sex: female Geographic origin: United Arab Emirates (UAE) Observation 3: Clinical Features: Primary dilated cardiomyopathy (present) Age: 10-19 years Sex: male Geographic origin: United Arab Emirates (UAE) Observation 4: Age: 10-19 years Sex: female Geographic origin: United Arab Emirates (UAE) Observation 5: Age: 0-9 years Sex: female Geographic origin: United Arab Emirates (UAE) Observation 6: Age: 0-9 years Sex: male Geographic origin: United Arab Emirates (UAE) Observation 7: Sex: mixed Method: Echocardiography were performed after 72 hours of tunicamycin injection (2 mg/kg body weight). Mice were anesthetized with inhalation of isoflurane (1.5% in oxygen). The mouse chest was shaved and placed with ultrasound transmission gel. M-mode echocardiography was performed using Mindray Ultrasound and a 30-MHz transducer to access the following parameters: left ventricular internal diameter end diastole (LVIDd), left ventricular internal diameter end systole (LVIDs), left ventricular fractional shortening (LVFS), and left ventricular ejection fraction (LVEF). Result: We observed that Bag5-/- mice treated with tunicamycin exhibited a significant reduction in left ventricular ejection fraction (LVEF).

Germline Functional Evidence

Functional Help The functional consequence of the variant, based on experimental evidence and provided by the submitter. consequence	Method Help A brief description of the method used to determine the functional consequence of the variant. A citation for the method is included, when provided by the submitter.	Result Help A brief description of the result of this method for this variant.	Submitter Help The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar.	More information Help This column includes more information supporting functional evidence for the germline classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter.
protein loss of function (VariO:0043)	Echocardiography were performed after 72 hours of tunicamycin injection (2 mg/kg body weight). Mice were anesthetized with inhalation of isoflurane (1.5% in oxygen). The mouse chest was shaved and placed with ultrasound transmission gel. M-mode echocardiography was performed using Mindray Ultrasound and a 30-MHz transducer to access the following parameters: left ventricular internal diameter end diastole (LVIDd), left ventricular internal diameter end systole (LVIDs), left ventricular fractional shortening (LVFS), and left ventricular ejection fraction (LVEF).	We observed that Bag5-/- mice treated with tunicamycin exhibited a significant reduction in left ventricular ejection fraction (LVEF).	Center of Excellence for Medical Genomics, Chulalongkorn University Accession: SCV003918808.1	Publications PubMed (1)

Citations for germline classification of this variant

Title	Author	Journal	Year	Link
Loss-of-function mutations in the co-chaperone protein BAG5 cause dilated cardiomyopathy requiring heart transplantation.	Hakui H	Science translational medicine	2022	PMID: 35044787

Text-mined citations for this variant ...

Record last updated Aug 26, 2023

ClinVar Genomic variation as it relates to human health

NM_001015048.3(BAG5):c.321_322del (p.Lys108fs)

Variant Details

Genes

Conditions - Germline

Submissions - Germline

Germline Functional Evidence

Citations for germline classification of this variant

Text-mined citations for this variant ...